PS1556 BRUTON TYROSINE KINASE INHIBITOR IS AN EFFECTIVE STEROID‐SPARING AGENT IN CHRONIC GRAFT‐VERSUS‐HOST DISEASE

Ibrutinib, Medicine, Bruton's tyrosine kinase, Internal medicine, Refractory (planetary science), Graft-versus-host disease, Oncology, Disease, Tyrosine kinase, Leukemia, Chronic lymphocytic leukemia, Receptor, Biology